Stein, Eytan M.
Yang, Min
Guerin, Annie
Gao, Wei
Galebach, Philip
Xiang, Cheryl Q.
Bhattacharyya, Subrata
Bonifacio, Gaetano
Joseph, George J.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 2 April 2018
Accepted: 6 September 2018
First Online: 21 September 2018
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved under the exemption category from the New England Institutional Review Board.
: Not applicable.
: E.S. has received consultancy fees and/or research funding from Novartis, Agios Pharmaceuticals, Celgene Corporation, Pfizer, GSK, Seattle Genetics, and Constellation Pharma. G.B., S.B., and G.J.J. are employees of Novartis Pharmaceuticals Corporation and own stock/stock options. M.Y, A.G, W.G, P.G., and C.X. are employees of Analysis Group, Inc., which has received consultancy fees from Novartis Pharmaceuticals Corporation.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.